Introduction
Epithelial ovarian cancer (EOC) is the leading cause of cancer death among women, and it causes the most mortality among all gynecologic cancers. With EOC, the majority of patients are diagnosed with an advanced stage, which is usually managed with surgical cytoreduction and commonly followed by platinum-based chemotherapy [2, 3] .
In practice, many patients respond poorly to this initial chemotherapy with little or no benefit due to their platinumresistance.
To support the treatment of ovarian cancer, Koti et al. [1] identified genomic markers predictive of response to chemotherapy which can be used for patient selection during clinical development and beyond. They used two statistical methods to identify the genomic markers: (1) Welch t-statistic, and (2) non-parametric Mann-Whitney U test. The Welch procedure generated a list of 434 probesets, while the Mann-Whitney method then reduced this to a collection of 310 probesets. Finally, Koti et al. [1] proposed 204 genes, after considering the redundant probesets that corresponded to duplicated genes. Koti et al. [1] applied two statistical methods that turned out to be unsuitable for analyzing microarray data because a large number of probesets were included in the study. Moreover, there were always some probesets with very small variances across samples, so their (absolute) t-values were significant regardless of whether or not the differences Abstract: Treatment with chemotherapy is important in limiting the intensity of serous epithelial ovarian cancer. However, not all patients are sensitive to platinum chemotherapy corresponding to longer progression-free survival (PFS >8 months).
Koti et al. [1] revealed a set of 204 discriminating genes possessing expression levels, which could influence differential chemotherapy response between the platinum-resistant and platinum-sensitive group of patients. They considered Welch two-sample t-test and non-parametric Mann-Whitney U test to identify the differentially expressed genes. However, both the statistical methods turned out to be unsuitable for microarray data. In this paper, we used three alternative statistical methods to select a combined list of genes and compared the genes that were proposed by Koti et al. [1] . Subsequently, we recommended using sparse principal component analysis (sparse PCA) to identify a final list of genes. Sparse PCA incorporates correlation into account among the genes and helps to draw a biologically important gene discovery. We identified 77 differentially expressed genes, which include 11 new genes that can separate the groups of patients who are platinum-resistant and platinum-sensitive to the chemotherapy. The integrative approach can also be effective in another high dimensional dataset to compare between two groups. in their averages were large ( Figure 1 ). Therefore, there was a chance of having false positive genes in applying the t-statistic. Again, the mean t-value of the statistic is highly influenced by extreme observations, and hence is unsuitable for data with small samples. Figure 1 (a) presents the variances corresponding to the treatment effect (i.e., absolute mean) for the expression values of the EOC dataset samples [1] . It appears that a few of the probesets have low variability with high absolute mean effects, which cause the t-statistic to be high and increase the chance of selecting false positive genes. It confirms the presence of many probesets with large variances compared to the mean (i.e., the coefficient of variation in the denominator) in Figure 1 (b). Again, Mann-Whitney U test does not consider a variance from expression values. Moreover, Koti et al. [1] did not consider the correlation among the probesets. These limitations in the application of the methods by Koti et al. [1] motivated us to use an alternative approach by integrating three popular statistical methods with sparse principal component analysis (sparse PCA) to get the differentially expressed genes from the EOC data. Microarrays monitor the expression of thousands of genes at once, and it has become a challenge to unveil the relevant genes when considering all genes simultaneously. In this study, we present an approach by integrating statistical methods to discover novel biological mechanisms and reveal insightful patterns, while reducing the dimension of the data. A flowchart of the analysis plan is given in Figure 2 . A similar type of work plan with a high dimensional data was given in a paper by Hossain and Khan [4] . Both the parametric and non-parametric methods are commonly used to detect differentially expressed genes (DEGs). The most common parametric methods to find DEGs are the t-test and its variations. Tusher et al. [5] proposed a method called significance analysis of microarray (SAM) that identifies statistically significant genes by computing gene-specific non-parametric statistic, which measures the strength of the relationship between gene expression and a response variable. Smyth [6, 7] suggested a moderated t-statistic (LIMMA), which 
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computes a generalized form of the sample standard deviation. Both the SAM and moderated t-statistic were corrected for multiple hypotheses by using the BenjaminiHochberg method to determine the false discovery rate (FDR) [8] . The Wilcoxon rank sum test (RST) and area under the receiver operating characteristic curves (AUC) are equally popular in gene expression analysis [9] [10] [11] . In this paper, we applied three popular statistical methods of LIMMA, SAM, and AUC. Principal component analysis (PCA) is a multivariate dimension reduction and visualization technique that produces principal components (PCs) with linear combinations of the original variables. The limitation of PCA is that PCs are composed of all original variables, which is unrealistic in high-dimensional data and confusing since the interpretation of PCs is near impossible with a wide range of biomarkers. A new extension to classical PCA, the sparse PCA, systematically forces all original variables with a residual contribution to have 0-valued loadings, therefore attaining a more concise and realistic list of genes from the data. The sparse PCA gives a more interpretable set of PCs for further analysis [12, 13] . In this paper, we applied the sparse PCA using elastic net to summarize the gene expression profile. 
Materials and Methods
The data
The study sample of 28 locally advanced EOC tumors was obtained from Ontario Tumor Bank and the Ottawa Hospital Research Institute (OHRI). The data was obtained from Gene Expression Omnibus (GEO), accessible through GEO series accession number GSE51373. The data contained an expression of 54,675 probesets (i.e. variables). 28 patients were used for identifying genomic markers that may predict response to chemotherapy, using progressionfree survival (PFS) time as a surrogate of drug response. There were 12 of them who were platinum-resistant to chemotherapy, corresponding to shorter PFS (<8 months), and 16 were platinum-sensitive to the chemotherapy (PFS >18 months). Thus, the matrix to be analyzed had 54,675 rows of probesets and 28 columns of conditions corresponding to each sample. Details about the dataset can be found in the paper of Koti et al. [1] . They proposed a list of 204 genes that can be used to classify patients with sensitivity and resistance to the platinum-based chemotherapy. Starting with the 54,675 probesets collected from GEO, we filtered out the bottom 75% by using Inter-Quartile Range (IQR) and retained only the 10,587 most variable probesets. We removed probe sets that had very little variation. We transformed all gene expression values using log base 2 to achieve distributions closer to normal.
Statistical Methods
We applied three standard methods to identify differentially expressed genes, and later we used sparse PCA method. The methods are described briefly as follows:
t-test and its variation
The simplest method to detect differential gene expression is by a ranking based on the fold change (FC) or a ratio of expression means between the two conditions. A widely used alternative method is a t-test. With a large number of genes in this experiment, there were some genes with very small variances across samples which may give large t-values regardless of whether the differences in their averages were large. This could turn into a selection of many false-positive genes. Several alternative statistics have been proposed to overcome this problem, and many of them are influenced by the theory of shrinking the variance [5, 6, 8] . In this paper, we carried out probeset-specific test to measure the strength of the relationship between expression and the sensitivity/resistance to platinumbased chemotherapy. The moderated t (LIMMA) and SAM perform better for small sample sizes, and both pool information across many genes, thereby maintaining the underlying correlation structure of the genes. Both methods suffer from the presence of outliers in the data. We took the top 400-ranked probesets after adjusting for false discovery rate (FDR), although Koti et al. [1] considered their top 434
genes by considering p-values at 1% significance level.
Moderated t-statistics, p-values, and FDR-adjusted p-values
were calculated using the LIMMA package [7] and SAM was calculated using samr package in R [14] .
Area under receiver operating characteristic curve
Troyanskaya et al. [15] applied the Wilcoxon rank sum test (RST) to identify DEGs. The RST is a non-parametric alternative to the two-sample t-test, which is based solely on the rank of the expression values in which the observations from the two groups fall. However, the method is not ideal for small sample size because of its poor performance in identifying true positive and true negative genes. As the sample size increases, the statistical power of the Wilcoxon RST increases. An assessment of the expression of a gene can also be made through the use of a receiver operating characteristic (ROC) curve, which allows the consideration of the agreement between expression values and the presence of different thresholds simultaneously. Pepe et al. argued that the two measures related to the ROC curve are suitable for ranking genes in regards to differential expression between two conditions: the area under the ROC curve (AUC) and the partial AUC (pAUC) [9] . The AUC is a probability that a randomly selected subject from a treatment group has greater expression values than a randomly selected subject from a control group. For continuous genomic data, the non-parametric ROC curve may be preferred since it passes through all observed points and provides unbiased estimates of sensitivity, specificity, and AUC in large samples. We calculated the non-parametric AUC for the expression data by using the R package WLpAUC downloaded from SIGMA website [11] .
Using the EOC data, we considered the top 400 probesets by considering the AUC values greater than 0.80.
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Sparse PCA
Principal components analysis (PCA) is a standard tool for determining the key variables in a multidimensional data set if the biological question is related to the highest variance [16] . PCA first attempts to maximize the variance of noisy signals, which has a normal distribution, before being able to find the right direction to differentiate better the sample classes. The main downfall of PCA from a regression standpoint is the interpretation. For a particular principal component (PC) (linear combination), the loadings (coefficients) represent the contribution of each original variable, but if there are a large number of variables, it could be very hard to determine exactly what the PC represents. The application of PCA to a genomic data does not allow summarizing the ways in which gene expressions vary under two biological conditions. The variance accounted for by each of the components is its associated eigenvalue, the variance of a component over all genes. Consequently, eigenvectors with large eigenvalues are the ones that contain most of the informationeigenvectors with small eigenvalues are uninformative [16] .
PCA suffers from the fact that each principal component is a linear combination of all the original variables. Thus it is often difficult to interpret the results. In this circumstance, we applied the sparse PCA using the lasso (or elastic net) to produce modified principal components with sparse loadings [12, 13] . We used the sparse PCA function from the R-package "elasticnet" to get six sparse principal components (PCs) [17] .
Results
We applied SAM, moderated t-statistic (LIMMA), and AUC to the EOC expression data and obtained three separate lists of top ranked 400 probesets. The three different gene lists were produced after gene annotation. The Venn diagram in Figure 3 shows the top ranked genes by each of the statistical method and Koti et al [1] . We found 66 genes that overlapped among these methods. This diagram gives a better insight into the biological study as it reveals the shared similarities among the methods.
In an attempt to visualize some block-structure, we used a clustering algorithm to align these genes as would be needed to draw a dendrogram [18, 19] . We applied the hierarchical clustering technique to predict sensitive/ resistance to platinum-based chemotherapy, and we presented a heatmap in Figure 4 . The heatmap shows patterns of color where the samples and genes are associated and therefore attempt to accomplish one of the missions sparse PCA sets out: to find natural groupings of genes. This heatmap allows the visualization of how the 66 genes partition the samples that reflect the internal structure of the data and extract the relevant information to present each sample. We expect that the samples from the same biological group would be clustered together and thus separated from the other groups. Moving to joint associations of genes, we built six sparse PCs from the correlation matrix of the data by using the sparse PCA method. We defined the number of sparse loadings to be obtained using penalty parameter as 0.06, 0.16, 0.1, 0.5, 0.5 and 0.5 for the six sparse PCs, respectively. Thus, we found 27 non-zero loadings in the first sparse principal component and eight non-zero loadings in the sixth sparse principal component. The nonzero elements of the loading vectors are presented in Table  1 . Of the first six sparse PCs we investigated, the total percentage of genes variance explained by the first PC was 7.08%. This is a substantial amount, considering that about 98% of the loadings were forced to 0, which validated the ability of sparse PCA as a dimension reduction technique. We found 16 common genes that were in both the list of 66 genes and SPC1. Therefore, the first PC seemed sufficient to separate the two groups. With the 11 new genes identified, we had a total of 77 genes, which are listed in Table 2 . [1] , and it appears that 66 genes are commonly found by these methods Table 1 . Genes with nonzero loadings for the first 6 sparse principal components
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To further highlight potential blocks of variables, the same image strategy by a heatmap in Figure 5 was used on the sample correlation matrix. It shows a well-separated cluster in the sample, especially with the separation improved to 77 genes compared to the 66 genes. Finally, we examined (through published work) the ovarian cancer staining for the 11 new genes not identified by Koti et al. [1] , which are given in Table 3 . It appears that most of the new genes given in Table 3 are identified as having moderate-tostrong nuclear positivity for ovarian cells. Our aim was to narrow down only a few genetic variants to aid researchers in further exploration; in this regard we give a very concise list of 77 genes.
Discussion and Conclusion
The treatment of patients with advanced-stage ovarian cancer is empiric, and almost all patients receive a platinum chemotherapy. Therefore, it is important to know the group of patients who are resistant to this chemotherapy. For the purpose of this study, we used an integrative approach to the EOC expression data and we narrowed down only a few genes in order to aid researchers in further exploration. The sparse PCA method provides a new insightful way to detect important features of the data by using correlation among genes into account. This research is motivated by the belief that the sparse PCA method might highlight relevant information in taking the correlation among genes with the ovarian cancer patients, since correlation among genes are very common. In this regard, we suggested 11 new genes that were not identified by Koti et al. [1] . We proposed a list of 77 genes, which are given in Table 2 . Besides, we found that most of the new genes given in Table 3 were identified as having moderate-to-strong nuclear positivity for ovarian cells. Hence, we suggest researchers to focus on these 77 genes for further analysis. The study aims to narrow down number of genes that have changed significantly regarding their expression between sensitivity and resistant to the platinum-based chemotherapy for EOC patients. Overall, the results of genes have given us a better understanding in classifying samples that are associated with either sensitivity or resistant to chemotherapy for ovarian cancer. Hence, the selected genes need a further investigation that can output pathways, process networks, Gene Ontology (GO) processes and molecular functions.
Given the list of genes which include 11 newly identified Table 2 . 77 correlated genes with sensitivity/resistant of platinum chemotherapy genes, we conclude that the gene expression profiles may have the capacity to predict response to platinum-based chemotherapy and thus may serve as a mechanism to stratify patients for treatment. The resulting genes could give more insight into the expected biological characteristics of the samples. We anticipate that the present study will help to add scientific knowledge in medical research, especially the use of platinum-based chemotherapy for cancer patients, by taking into consideration the new set of the gene list. Besides, the analytical procedures that were applied in the study can also be a useful guideline to analyze another similar type of genomic data.
